Rhythm Pharmaceuticals, Inc. RYTM Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported increase (decrease) in prepaid expense and other assets of $487K in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 84.8% year-over-year, from $3.2M to $487K.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.